Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)
Clinical trial NCT00954993 · TERMINATED
Trial details
- NCT number
- NCT00954993
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-13
- Primary completion
- 2011-03-04
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.